Antimycotic treatment in children

European Journal of Pediatric Dermatology

Volumn 10, Issue 1, 2000, Pages 33-37

  Bonifazi, E ^a   Berloco, A ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; CANDIDIASIS; CHILD; DERMATOMYCOSIS; GLABROUS SKIN; HUMAN; IMMUNOCOMPETENCE; MYCOSIS; ONYCHOMYCOSIS; REVIEW; SPOROTRICHOSIS; TINEA VERSICOLOR;

EID: 0034491875     PISSN: 11227672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Evaluation of adult carrier state in juvenile tinea capitis caused by Tricophyton tonsurans
2. Risk of acute liver injury among users of oral antifungals: A population-based study
3. Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor
4. Levels of terbinafine in plasma, stratum corneum, dermisepidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days
5. The management of tinea capitis: An update
6. Higher dose of oral terbinafine is required for Microsporum canis tinea capitis
7. Current status of the identification and management of tinea capitis
8. Successful treatment of candidiasis with transfer factor
9. Post treatment itraconazole levels in the nail